Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Anika Therapeutics 32 WIGGINS AVENUE BEDFORD MA 01730 USA

www.anika.com Employees: 357 P: 781-457-9000 F: 781-305-9720

Description:

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative pain management to regenerative cartilage repair. Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.

Key Statistics

Overview:

Market Capitalization, $K 251,618
Enterprise Value, $K 178,748
Shares Outstanding, K 14,646
Annual Sales, $ 166,660 K
Annual Net Income, $ -82,670 K
Last Quarter Sales, $ 38,750 K
Last Quarter Net Income, $ -29,920 K
EBIT, $ -34,510 K
EBITDA, $ 41,900 K
60-Month Beta 0.86
% of Insider Shareholders 7.86%
% of Institutional Shareholders 91.53%
Float, K 13,495
% Float 92.14%
Short Volume Ratio 0.35

Growth:

1-Year Return -15.63%
3-Year Return -56.04%
5-Year Return -69.84%
5-Year Revenue Growth 57.88%
5-Year Earnings Growth -116.30%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 10/31/24
Next Earnings Date N/A
Earnings Per Share ttm -0.30
EPS Growth vs. Prev Year 293.49%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ANIK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2.22%
Return-on-Assets % -1.75%
Profit Margin % -49.60%
Debt/Equity 0.00
Price/Sales 1.50
Price/Cash Flow 3.46
Price/Book 1.39
Book Value/Share 12.28
Interest Coverage -0.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar